How a PE Fund Uncovered Hidden Regulatory Risk in an India Healthcare Acquisition

A mid-market private equity fund was running diligence on a diagnostics services chain with operations across four Indian states. The financials looked strong. The management team was credible. The growth case was built on a combination of organic expansion and further franchise acquisitions.

Global private equity dry powder reached 2.59 trillion dollars in early 2026, with deal purchase multiples climbing to 11.8x EBITDA. At those prices, getting the commercial thesis wrong is catastrophic.

The situation: a shortlist that did not answer the real questions

The fund had already requested an expert shortlist from their existing expert network provider. They received profiles five days later. Three of the five experts were based outside India. Of the two India-based experts, neither had operated in the specific states where the target had its highest revenue concentration. The conversations produced generic sector commentary rather than target-specific intelligence. They brought the project to Nextyn.

What Nextyn did differently

The brief was specific: the fund needed former state health ministry officials who had worked on reimbursement policy in the two states where the target's collection network was most concentrated, and operators who had competed directly with the target or operated in the same franchise model.

Nextyn's shortlist was delivered within 36 hours. It included two former state health ministry officials from the relevant states, a competing diagnostics operator who had navigated a franchise network expansion in the same geography, and a pathology laboratory equipment supplier who had visibility into the target's capital expenditure patterns across the previous three years.

The finding that changed the deal

In the first call with a former state health department official, the fund's analyst asked about the stability of state health insurance reimbursement rates for pathology services. The official described a policy review that had been quietly underway for several months. The review had not been publicly announced. It was not referenced in any document the target had provided.

The second state conversation confirmed a similar dynamic. Both states were reviewing reimbursement rates for private diagnostic providers. The direction of the review was toward rationalisation, with rate reductions expected for high-volume, low-complexity pathology tests that represented a significant portion of the target's state insurance revenue.

The competing diagnostics operator provided context on the likely impact. They had managed through an equivalent review in a different state two years earlier and described how it had compressed revenue per test by approximately 12 to 18 percent for the affected test categories before stabilising.

How the intelligence was used

The fund did not walk away from the deal. The business remained attractive. What changed was the financial model and the deal structure. The fund's analysts rebuilt the revenue projections using conservative assumptions for the two affected states. The impact on EBITDA, at the acquisition multiple being discussed, was material.

The fund introduced two structural protections into the transaction. An earn-out component tied the portion of consideration reflecting state insurance revenue growth to actual post-close reimbursement rates in both states. An indemnity provision covered any retroactive rate adjustment for the period after the signing date. The deal closed on better terms than the original structure would have produced.

What this engagement illustrates

India healthcare diligence requires practitioners who are actively present in the specific markets being evaluated. Remote sourcing from a global database produces available experts, not necessarily relevant ones. The intelligence that changed this deal came from a former state official who knew what was happening in a specific government review that had not yet reached the public domain. Finding that person required a network built on relationships, not a database built on resumes.